New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis
Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications
Inadequate hospital practices to prevent mother-to-child transmission of Hepatitis B Virus infection: A European survey
SMILE once-daily regimen non-inferior to triple ART regimen
COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa
O32 Using rapid qualitative inquiry for implementation support in a multinational study on infection prevention and control in neonatal intensive care
Inaugural training session for UNIVERSAL’s Clinical Trial Management course
Penta signs the 2022 Rome Action plan to intensify commitment to scaling up prevention, diagnosis and treatment of paediatric HIV and TB
Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies
🇬🇧 Penta unveils Brighter Future Award 2023: Recognising innovators and visionaries driving positive change
Nominations are open for the Penta Brighter Future Award!
Lessons learned from the HIV pandemic to strengthen qualitative research methods for (re)emerging infections
Join the webinar “Facilitating clinical evaluation of novel products for children” on 14 June
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Global study highlights deaths from neonatal sepsis and steps to improve treatment
🇮🇹 Sepsi nei neonati: ancora alta la mortalità nel mondo. Nuovi strumenti per facilitare diagnosi e cura